Some complications of the therapy of hemorrhagic disorders.
The principal mode for treating disorders of hemostasis is correction of the patient's functional defect by transfusions of appropriate fractions of normal plasma or transfusions of platelets. Two major complications of such therapy are the transmission of infectious diseases, particularly hepatitis and the acquired immune deficiency syndrome (AIDS), and the development of antibodies against clotting factors that are deficient in the patient's plasma. Measures that reduce the occurrence of infection include careful selection of donors, fractionation of plasma with the help of monoclonal antibodies, and treatment of plasma or its fractions with heat or with virus-inactivating organic solvents. No technique of preparing or administering blood or its components can prevent the emergence of antibodies against clotting factors. Desensitization by repeated infusions of antigen, for example, antihemophilic factor, however, appears to result in remission in some patients.
Ratnoff
O D
OD
Department of Medicine, School of Medicine, Case Western Reserve University, University Hospitals of Cleveland, Ohio.
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission; D001778:Blood Coagulation Disorders / Q000628:therapy*; D001803:Blood Transfusion / Q000379:methods; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D010951:Plasma Exchange / Q000009:adverse effects; D017713:Platelet Transfusion; D065227:Transfusion Reaction